Cardiac Imaging Advancements: Diagnosis, Risk, Treatment
*Corresponding Author: Dr. Ahmed El-Sayed, Department of Cardiac Imaging, Cairo Medical University, Egypt, Email: a.elsayed@cardiorad.egReceived Date: Mar 03, 2025 /
Citation: El-Sayed DA (2025) Cardiac Imaging Advancements: Diagnosis, Risk, Treatment. J Radiol 14: 673DOI: 10.4172/2167-7964.1000673
Copyright: © 2025 Dr. Ahmed El-Sayed This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Abstract
This compilation explores the latest advancements and clinical applications of key cardiac imaging modalities. It covers the roles of Cardiac Magnetic Resonance Imaging (CMR) in ischemic heart disease, Artificial Intelligence (AI) in Cardiac CT Angiography (CCTA), echocardiography for valvular disease, Dual-Energy CT (DECT) for mass and thrombi characterization, CCTA for asymptomatic individuals, Gated SPECT Myocardial Perfusion Imaging (MPI), 4D Flow MRI in congenital heart disease, CTCA for acute chest pain, Cardiac PET for sarcoidosis, and Coronary Artery Calcium (CAC) scoring for risk assessment. These technologies collectively enhance diagnostic accuracy, risk stratification, and treatment guidance in cardiovascular medicine.
